Clinical Trials Logo

Clinical Trial Summary

The objectives of this trial is to evaluate efficacy and safety of treatment with Trabectedin in a large cohort of German patients with soft tissue and bone sarcomas.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03284320
Study type Observational
Source University Medicine Greifswald
Contact
Status Completed
Phase
Start date April 18, 2017
Completion date November 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04122872 - GISAR German Interdisciplinary Sarcoma Registry
Recruiting NCT06074692 - PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) Phase 2
Recruiting NCT04616248 - In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors Phase 1
Terminated NCT02199938 - Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
Recruiting NCT05057130 - Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors Phase 2/Phase 3
Recruiting NCT05057143 - 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors N/A
Terminated NCT02775799 - National Swiss Sarcoma Cohort Study